147 related articles for article (PubMed ID: 26113466)
1. Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure-Function Analysis.
Ligumsky H; Rubinek T; Merenbakh-Lamin K; Yeheskel A; Sertchook R; Shahmoon S; Aviel-Ronen S; Wolf I
Mol Cancer Res; 2015 Oct; 13(10):1398-407. PubMed ID: 26113466
[TBL] [Abstract][Full Text] [Related]
2. KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer.
Abramovitz L; Rubinek T; Ligumsky H; Bose S; Barshack I; Avivi C; Kaufman B; Wolf I
Clin Cancer Res; 2011 Jul; 17(13):4254-66. PubMed ID: 21571866
[TBL] [Abstract][Full Text] [Related]
3. The Hormone KL1: A Regulator of Breast Cancer Cell Metabolism.
Davidov B; Shmulevich R; Shabtay A; Rubinek T; Wolf I
Isr Med Assoc J; 2019 Jul; 21(7):504. PubMed ID: 31507133
[TBL] [Abstract][Full Text] [Related]
4. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
Wolf I; Levanon-Cohen S; Bose S; Ligumsky H; Sredni B; Kanety H; Kuro-o M; Karlan B; Kaufman B; Koeffler HP; Rubinek T
Oncogene; 2008 Nov; 27(56):7094-105. PubMed ID: 18762812
[TBL] [Abstract][Full Text] [Related]
5. Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho.
Abboud M; Merenbakh-Lamin K; Volkov H; Ben-Neriah S; Ligumsky H; Bronfeld S; Keren-Khadmy N; Giladi M; Shomron N; Wolf I; Rubinek T
Oncogene; 2024 Jan; 43(5):354-362. PubMed ID: 38040805
[TBL] [Abstract][Full Text] [Related]
6. Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho.
Chen CD; Li Y; Chen AK; Rudy MA; Nasse JS; Zeldich E; Polanco TJ; Abraham CR
PLoS One; 2020; 15(1):e0226382. PubMed ID: 31929539
[TBL] [Abstract][Full Text] [Related]
7. Klotho suppresses colorectal cancer through modulation of the unfolded protein response.
Arbel Rubinstein T; Shahmoon S; Zigmond E; Etan T; Merenbakh-Lamin K; Pasmanik-Chor M; Har-Zahav G; Barshack I; Vainer GW; Skalka N; Rosin-Arbesfeld R; Varol C; Rubinek T; Wolf I
Oncogene; 2019 Feb; 38(6):794-807. PubMed ID: 30232408
[TBL] [Abstract][Full Text] [Related]
8. Subtle Difference Generates Big Dissimilarity: Comparison of Enzymatic Activity in KL1 and KL2 Domains of Lancelet Klotho.
Ma Z; Qu B; Zhong S; Yao L; Gao Z; Zhang S
Mar Biotechnol (NY); 2019 Aug; 21(4):448-462. PubMed ID: 31053952
[TBL] [Abstract][Full Text] [Related]
9. The aging suppressor klotho: a potential regulator of growth hormone secretion.
Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
[TBL] [Abstract][Full Text] [Related]
10. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
Wright JD; An SW; Xie J; Yoon J; Nischan N; Kohler JJ; Oliver N; Lim C; Huang CL
FASEB J; 2017 Aug; 31(8):3574-3586. PubMed ID: 28442546
[TBL] [Abstract][Full Text] [Related]
11. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
[TBL] [Abstract][Full Text] [Related]
12. Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.
Shmulevich R; Nissim TB; Wolf I; Merenbakh-Lamin K; Fishman D; Sekler I; Rubinek T
Oncogene; 2020 Jun; 39(24):4636-4649. PubMed ID: 32398866
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
[TBL] [Abstract][Full Text] [Related]
14. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
15. Klotho converts canonical FGF receptor into a specific receptor for FGF23.
Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T
Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194
[TBL] [Abstract][Full Text] [Related]
16. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
17. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Klotho Treatment on Atherogenesis, Blood Pressure, and Metabolic Parameters in Experimental Rodent Models.
Kamari Y; Fingrut O; Shaish A; Almog T; Kandel-Kfir M; Harats D; Rubinek T; Wolf I
Horm Metab Res; 2016 Mar; 48(3):196-200. PubMed ID: 25951321
[TBL] [Abstract][Full Text] [Related]
19. Identification of Small-Molecule Inhibitors of Fibroblast Growth Factor 23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-Klotho.
Liu SH; Xiao Z; Mishra SK; Mitchell JC; Smith JC; Quarles LD; Petridis L
J Chem Inf Model; 2022 Aug; 62(15):3627-3637. PubMed ID: 35868851
[TBL] [Abstract][Full Text] [Related]
20. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
